Nurses’ knowledge about safety in the clinical management of patients with influenza: a cross-sectional study
DOI:
https://doi.org/10.17058/reci.v15i1.19391Keywords:
Knowledge, Human Influenza, NurseAbstract
Background and Objectives: to assess nurses’ knowledge profile about the indications for the clinical management of influenza. Methods: descriptive cross-sectional study, carried out in October 2019. Sociodemographic and clinical variables were assessed of 53 nurses, compared using descriptive and univariate statistics. Results: nurses reported that returning to the health service to review the clinical condition is not an indication for the clinical management of patients with influenza-like syndrome (IS) with risk factors for complications (10; 19.0%). The indigenous population living in villages (3; 6.0%) and individuals under 19 years of age, in prolonged use of acetylsalicylic acid (36; 68.0%), are not/do not know that they are considered risk factors for complications. The use of symptomatic medications (5; 9.0%), the use of oseltamivir phosphate (16; 30.0%) and returning to the health service for review of the clinical condition (12; 23.0%) are not indications for the clinical management of patients with IS, without risk factors for complications, as well as the use of oxygen therapy, continuous monitoring and hospital admission if there are signs of worsening, including SatO2 <95% (3; 6.0%), the use of oseltamivir phosphate (3; 6.0%), the performance of a radiological examination (1; 2.0%) and the control of hyperthermia with paracetamol (4; 7.0%) are not/do not know that they are indications for the clinical management of pregnant/postpartum women. Conclusion: nurses’ knowledge is satisfactory, but there are doubts regarding the care of more specific patients, such as pregnant and postpartum women as well as the risk factors or conditions for complications.
Downloads
References
Espinoza CA, Peralta CL. Characterization of pre- and post-vaccination immunity with influenza in patients with human immunodeficiency virus. Collegiate Journal of Science 2018; 3(1): 30-45. http://portal.amelica.org/ameli/jatsRepo/334/3342538006/3342538006.pdf
Aoyama EA, Nunes ECA, Oliveira MS et al. Os benefícios da vacina H1N1 em idosos. Brazilian Journal of health. 2019; 2(1):185-191. https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/880/762
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento de Articulação Estratégica de Vigilância em Saúde e Ambiente. Guia de vigilância em saúde: volume 3. 6.ed. Brasília: Ministério da Saúde; 2023. https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_6ed_v3.pdf
Molin RSD. Saúde em Foco: Doenças Emergentes e Remergentes. In: Ribeiro JF, Bellei NCJ, Chaves NSG et al. Influenza (Gripe1). 1 ed. Brasil: Editora Científica Digital; 2020. p.2-31. https://doi.org/10.37885/201001751
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento do Programa Nacional de Imunizações e Doenças Imunopreviníveis. Guia de Manejo e Tratamento de Influenza 2023. Brasília: Ministério da Saúde; 2023.
World Health Organization: WHO and World Health Organization: WHO, “Influenza (Seasonal)”; 2023. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Informe Vigilância das Síndromes Gripais. Influenza, Covid-19 e outros vírus respiratórios de importância em saúde pública. Semana epidemiológica 2. 26 de setembro de 2024. https://www.gov.br/saude/pt-br/assuntos/covid-19/atualizacao-de-casos/informe-se-37-de-2024.pdf/view
CEARÁ. Governo do Estado. Informe operacional Cenário epidemiológico dos vírus respiratórios. Nº 03. Atualização em: 26/09/2024. https://www.saude.ce.gov.br/wp-content/uploads/sites/9/2020/02/INFORME-No3-Cenario-epidemiologico-dos-virus-respiratorios-2024.pdf
Malta M, Cardoso LO, Bastos FI et al. Iniciativa STROBE: subsídios para a comunicação de estudos observacionais. Rev Saude Publica. 2010; 44(3):559-65. https://doi.org/10.1590/S0034-89102010000300021
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Protocolo de Tratamento de Influenza. Brasília; 2017. https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_tratamento_influenza_2017.pdf
Moreno M, Pérez-Martín J, Mañueco, MR. Parents and teachers’ perspectives on a school-located influenza vaccination program: A pilot study in the Region of Murcia, Spain. Human Vaccines & Immunotherapeutics. 2024; 20(1):1-8. https://doi.org/10.1080/21645515.2024.2328406
BRASIL. Ministério da Saúde. Política Nacional de Atenção Básica - Portaria no 2.436, de 21 de setembro de 2017. Brasília: MS; 2017. Disponível em: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html
Holanda WTG, Oliveira SB, Sanchez MN. Differential aspects in the access to and quality of primary health care within the scope of the vaccine coverage for influenza. Ciência & Saúde Coletiva. 2022; 27(4): 1679-94. https://doi.org/10.1590/1413-81232022274.03472021
Di Bella S, Luzzati R, Principe L. et al. Aspirin and infection: A narrative review. Biomedicines 2022; 10(2): 263. https://doi.org/10.3390/biomedicines10020263
Chapman J, Arnold JK. Reye syndrome. In StatPearls. StatPearls Publishing: Treasure Island; 2023. https://www.ncbi.nlm.nih.gov/books/NBK526101/
Abd El- hadi H. Mini analytical review of different techniques applied for oseltamivir phosphate estimation in various matrices. ERU Research Journal. 2024; 3(1): 837-848. https://doi.org/10.21608/erurj.2024.337762
Bernardi BA, Marcolin P, Lindemann IL et al. Prevalência de Influenza A, vírus sincicial respiratório e SARS-COV-2 em pacientes com síndrome respiratória aguda grave em Passo Fundo - RS. Semin. Cienc. Biol. Saude. 2023; 44(2):113-26. https://doi.org/10.5433/1679-0367.2023v44n2p113
Blanchard-Rohner G, Eberhardt C. Review of maternal immunisation during pregnancy: focus on pertussis and influenza. Swiss Med Wkly. 2017; 147(4344):w14526. https://doi.org/10.4414/smw.2017.14526
Bulloch MN. Treatment and prevention of influenza in geriatric patients. Expert Review of Clinical Pharmacology. 2023; 16(9), 825–841. https://doi-org.ez11.periodicos.capes.gov.br/10.1080/17512433.2023.2243221
Grohskopf LA, Alyanak E, Broder KR et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2019–20 influenza season. MMWR Recomm Rep. 2019; 68(3): 1-21. http://dx.doi.org/10.15585/mmwr.rr6803a1
Razzaghi H, Kahn KE, Calhoun K et al. Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women — United States, April 2023. MMWR Morb Mortal Wkly Rep. 2023; 72:1065 - 1071. http://dx.doi.org/10.15585/mmwr.mm7239a4
Akmatova R, Ebama MS, Temirbekov S et al. A comparative analysis of knowledge, attitude, and practice (KAP) towards influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior to and during the COVID-19 pandemic. Vaccines. 2024. https://doi.org/10.1016/j.vaccine.2024.04.008.
Betancourt-Cravioto M, Falcón-Lezama JA, Saucedo-Martínez R et al. Public health and economic benefits of influenza vaccination of the population aged 50 to 59 years without risk factors for influenza complications in Mexico: a cross-sectional epidemiological study. Vaccines. 2021; 9(3):188. https://doi.org/10.3390/vaccines9030188
BRASIL. Ministério da Saúde. Política Nacional de Educação Permanente em Saúde: o que se tem produzido para o seu fortalecimento? Brasília: Ministério da Saúde; 2018. https://conselho.saude.gov.br/images/publicacoes2023/politica_nacional_educacao_permanente_saude_fortalecimento.pdf
Beck JL, Renner JDP, Carneiro M et al. Aspectos clínicos e sociodemográficos dos casos de Síndrome Respiratória Aguda Grave no sul do Brasil. Rev Epidemiol Control Infect. 2023; 13(3):1-14. https://doi.org/10.17058/reci.v13i3.17903
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Regina Kelly Guimarães Gomes Campos, Angélica Barreira Pinheiro, Samia Jardelle Costa de Freitas Maniva, Jéssica Lima Benevides, Rose-Eloíse Holanda

This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.